Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interdigitating Dendritic Cell Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00002625
What this trial is testing

Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Esophageal CancerLung CancerLymphoma
National Cancer Institute (NCI) 5
Early research (Phase 1)Study completedNCT00003993
What this trial is testing

Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Institute on Aging (NIA) 24
Not applicableStudy completedNCT00898157
What this trial is testing

Study of Biomarkers Using Tissue Samples From Older Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab on Clinical Trial ECOG-E4494

Who this might be right for
Lymphoma
ECOG-ACRIN Cancer Research Group 1,600
Testing effectiveness (Phase 2)Study completedNCT02561273
What this trial is testing

Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveHepatosplenic T-Cell Lymphoma+7 more
University of Nebraska 54
Testing effectiveness (Phase 2)Study completedNCT00268853
What this trial is testing

A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin

Who this might be right for
Diffuse Large-Cell Lymphoma
CTI BioPharma 124
Early research (Phase 1)Ended earlyNCT00004239
What this trial is testing

506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Alliance for Clinical Trials in Oncology 10
Testing effectiveness (Phase 2)Study completedNCT00078858
What this trial is testing

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more
Fred Hutchinson Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT00002908
What this trial is testing

Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT00089076
What this trial is testing

MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaCutaneous B-cell Non-Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT00293345
What this trial is testing

3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+56 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Ended earlyNCT01278615
What this trial is testing

Selumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Recurrent Adult Diffuse Large Cell Lymphoma
National Cancer Institute (NCI) 16
Testing effectiveness (Phase 2)Ended earlyNCT00851552
What this trial is testing

Bortezomib, Doxorubicin Hydrochloride Liposome, and Rituximab in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment

Who this might be right for
Lymphoma
Roswell Park Cancer Institute 9
Testing effectiveness (Phase 2)Study completedNCT00003396
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore 42
Early research (Phase 1)Active Not RecruitingNCT05621096
What this trial is testing

Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma

Who this might be right for
DLBCL - Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaFollicular Lymphoma+4 more
University of Nebraska 33
Early research (Phase 1)Study completedNCT00963274
What this trial is testing

Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Who this might be right for
LeukemiaLymphoma
Virginia Commonwealth University 18
Testing effectiveness (Phase 2)Study completedNCT00436618
What this trial is testing

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder
Mayo Clinic 277
Not applicableStudy completedNCT00899496
What this trial is testing

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Who this might be right for
Cancer
Wake Forest University Health Sciences 54
Testing effectiveness (Phase 2)Study completedNCT00002880
What this trial is testing

Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 53
Testing effectiveness (Phase 2)Study completedNCT00003913
What this trial is testing

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 390
Testing effectiveness (Phase 2)Ended earlyNCT02169505
What this trial is testing

Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT)

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 2
Next Page